Formulation and Evaluation of Nanosuspension of Mebendazole for Solubility Enhancement by High Pressure Homogenization Technique

DOI:

https://doi.org/10.37285/ijpsn.2024.17.3.5

Authors

  • Abhijit Patil Department of Pharmaceutics, Shri D. D. Vispute college of Pharmacy and Research Centre, New Panvel,
  • Gangotri Yadav Department of Pharmaceutics,Shri D. D. Vispute college of Pharmacy and Research Centre, New Panvel,
  • Bhushan Rane  Department of Pharmaceutics,Shri D. D. Vispute college of Pharmacy and Research Centre, New Panvel,
  • Ashish Jain Department of Pharmaceutics, Shri D. D. Vispute college of Pharmacy and Research Centre, New Panvel
  • Omkar Tambvekar Department of Pharmaceutics, Shri D. D. Vispute college of Pharmacy and Research Centre, New Panvel

Abstract

Background: Developing and evaluating a drug taken by mouth delivery method with mebendazole nanosuspension to treat intestinal worms infestations are the main objectives of the current research effort. This is because drug particles in the nano range help to reduce particle size and enhance dissolution.

Methods: By using High pressure homogenization method, the mebendazole is converted into nanosuspension. Various amounts of HPMC K4M used as a stabilizer and Tween 80 and Poloxamer 188 used as a surfactant and compare its ratios. The results were investigated using effectiveness of drug entrapment, saturation solubility, zeta potential, particle size, drug release study and stability testing.

Result: The drug purification results are shown by knowing the FT-IR spectrum. With a good entrapment efficiency and saturated solubility, optimized batches are found and the use of transmission electron microscopy confirms the nano size particle formed. The mebendazole nanosuspension showed higher release in the target site within 12 hours, according to an in-vitro dissolution experiment. Using the oral route for administration of the mebendazole nanosuspension, it increases the drugs absorption along with complete drug releasing.

Conclusion: The study indicates that the prepared mebendazole nanosuspension has increased the rate of dissolution and solubility by converting nano range particles and encouraging the use of BCS class Ⅱ drugs with acceptable stability.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Mebendazole, High pressure homogenization, Nanosuspension, Solubility, Particle size

Published

2024-06-30

How to Cite

1.
Patil A, Yadav G, Rane B, Jain A, Tambvekar O. Formulation and Evaluation of Nanosuspension of Mebendazole for Solubility Enhancement by High Pressure Homogenization Technique. Scopus Indexed [Internet]. 2024 Jun. 30 [cited 2024 Dec. 20];17(3):7353-6. Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/4302

Issue

Section

Research Articles

References

Sharma M, Sharma R, Jain DK. Nanotechnology Based Approaches for Enhancing Oral Bioavailability of Poorly Water Soluble Antihypertensive Drugs. Scientifica. 2016;1–11.

Mohammed MJ, Ali WK. Formulation and In-Vitro Evaluation of Two Layers Tablet for Dual Release of a Model Drug. International journal of drug delivery technology. 2023;13(01):45–56.

‌Muller RH, Gohla S, Keck CM. State of the Art of Nanocrystals – Special Features, Production, Nanotoxicology Aspects and Intracellular Delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2011;78(1): 1–9.

‌Merisko-Liversidge E, Liversidge GG. Nanosizing for Oral and Parenteral Drug Delivery: A Perspective on Formulating Poorly-Water Soluble Compounds Using Wet Media Milling Technology. Advanced Drug Delivery Reviews. 2011;63(6):427–440.

‌Muller RH, Jacobs C, Kayser O. Nanosuspensions as Particulate Drug Formulations in Therapy. Advanced Drug Delivery Reviews. 2001;47(1):3–19.

‌Ganesan P, Narayanasamy D. Lipid Nanoparticles: Different Preparation Techniques, Characterization, Hurdles, and Strategies for the Production of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Oral Drug Delivery. Sustainable Chemistry and Pharmacy. 2017;6:37–56.

Kanikkannan N. Technologies to Improve the Solubility, Dissolution and Bioavailability of Poorly Soluble Drugs. Journal of Analytical & Pharmaceutical Research 2018;7(1).

‌Hussain MS, Ahmed AB, Debnath J. Nanosuspension: a promising drug delivery system for poorly water soluble drug and enhanced bioavailability. Int J Pharm Sci & Res. 2020;11(10):4822-32.

‌Date AA, Hanes J, Ensign LM. Nanoparticles for Oral Delivery: Design, Evaluation and State-of-The-Art. Journal of controlled release. 2016;240:504–526.

Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: A Promising Drug Delivery Strategy. Journal of Pharmacy and Pharmacology. 2004;56(7):827–840.

Gudisa B. Anthelmintic Agents: Vermicide and Vermifuge. Insights in Biology and Medicine. 2022;6(1):001–008.

Torrado-Santiago, de la Torre-Iglesias PM, Torrado G, Torrado S, Bola F, Garcia JJ. Enhanced Bioavailability and Anthelmintic Efficacy of Mebendazole in Redispersible Microparticles with Low-Substituted Hydroxypropylcellulose. Drug Design, Development and Therapy. 2014;1467.

Zhang D, Tan T, Gao L, Zhao W, Wang P. Preparation of Azithromycin Nanosuspensions by High Pressure Homogenization and Its Physicochemical Characteristics Studies. Drug Development and Industrial Pharmacy. 2007;33(5):569–575.

‌Ethiraj T, Sujitha R, Ganesan V. Formulation and In-vitro Evaluation of Nanosuspension of Glimepiride. Int. J Pharmacy. 2013;3: 875-2.

Durgesh RP, Patil MP, Sonawane SS, Jain CP. Development and validation of Spectrophotometric method for Estimation of Mebendazole in bulk and Pharmaceutical Formulation. World Journal of Pharmaceutical Research. 2015;4(7):2222-2235.

Shrivastava S, Kaur CD. Development and Validation of Novel UV Spectrophotometric method for the Determination of Mebendazole in Pharmaceutical Formulation. International Journal of Pharmaceutical Sciences and Research. 2021;12(4):2317-2322.

Pooja J, Rahul B, Amir S. Preparation and Evaluation of Mebendazole Tablets by Using Liquisolid Technique to Enhance Its Dissolution Rate. International Journal of Pharmacy and Biological Sciences. 2020;10(2):152-161.

‌ Rao Y, Kumar M, Apte S. Formulation of Nanosuspension of Albendazole for Oral Administration. Current Nanoscience. 2008;4(1):53-58.

Sahu BP, Das MK. Nanosuspension for Enhancement of Oral Bioavailability of Felodipine. Applied Nanoscience. 2013;4(2):189–197.

Nayak S, Panda D, Patnaik AK. Formulation Design And In Vitro Characterization of Felodipine Nano-Suspension. International Journal of Pharmaceutical Sciences and Research. 2015;6(6):2587.

Pandya VM, Patel JK, Patel DJ. Formulation, optimization and characterization of Simvastatin Nanosuspension prepared by nanoprecipitation technique. Der Pharmacia Lettre. 2011;3(2):129-140.

Karadag A, Ozcelik B, Huang Q. Quercetin Nanosuspensions Produced by High-Pressure Homogenization. Journal of Agricultural and Food Chemistry. 2014;62(8):1852–1859.

Shid RL, Dhole SN, Kulkarni N, Shid SL. Formulation and evaluation of nanosuspension formulation for drug delivery of simvastatin. International Journal of Pharmaceutical Sciences and Nanotechnology. 2014;7(4):2650-2665.

Das S, Suresh PK. Nanosuspension: A New Vehicle for the Improvement of the Delivery of Drugs to the Ocular Surface. Application to Amphotericin B. Nanomedicine: Nanotechnology, Biology and Medicine. 2011;7(2):242–247.

Swamy NGN, Rupa V, Abbas Z, Dasankappa FS. Formulation and Evaluation of Nanosuspensions for Enhancing the Dissolution of Poorly soluble Mebendazole. Indian Drugs. 2010;47(9):47-54.

Agarwal V, Bajpai M. Stability Issues Related to Nanosuspensions: A Review. Pharmaceutical Nanotechnology. 2013;1(2):85–92.

Bhargav E, Barghav GC, Janardhan Reddy YC, kumar CP, Ramalingam P, Haranath CA. Design of Experiment (DoE) Based Approach for Development and Optimization of Nanosuspensions of Telmisartan, a BCS Class II Antihypertensive Drug. Future Journal of Pharmaceutical Sciences. 2020;6-14.